PRECIGEN, INC. Earnings Per Share (Basic)
PRECIGEN, INC. (PGEN) reported Earnings Per Share (Basic) of $0.06 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- PRECIGEN, INC. earnings per share, basic for the quarter ending 2026-06-30 was $0.06.
- PRECIGEN, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.02.
- PRECIGEN, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.07.
- PRECIGEN, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$1.06.
- PRECIGEN, INC. earnings per share, basic for fiscal 2025 was -$1.37.
- PRECIGEN, INC. earnings per share, basic for fiscal 2024 was -$0.47.
- PRECIGEN, INC. earnings per share, basic for fiscal 2023 was -$0.39, a 378.57% decline from fiscal 2022.
- PRECIGEN, INC. earnings per share, basic for fiscal 2022 was $0.14.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $0.06 10-Q · filed 2026-08-04 | $0.03 10-Q · filed 2026-08-04 | |||
| 2026-03-31 | -$0.02 10-Q · filed 2026-05-13 | ||||
| 2025-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$1.37 10-K · filed 2026-03-25 | ||
| 2025-09-30 | -$1.06 10-Q · filed 2025-11-13 | -$1.36 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | -$0.09 10-Q · filed 2026-08-04 | -$0.27 10-Q · filed 2026-08-04 | |||
| 2025-03-31 | -$0.18 10-Q · filed 2026-05-13 | ||||
| 2024-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-03-25 | -$0.47 10-K · filed 2026-03-25 | ||
| 2024-09-30 | -$0.09 10-Q · filed 2025-11-13 | -$0.41 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | -$0.23 10-Q · filed 2025-08-12 | -$0.33 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | -$0.10 10-Q · filed 2025-05-14 | ||||
| 2023-12-31 | -$0.39 10-K · filed 2026-03-25 | ||||
| 2023-09-30 | -$0.08 10-Q · filed 2024-11-14 | -$0.26 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | -$0.08 10-Q · filed 2024-08-14 | -$0.18 10-Q · filed 2024-08-14 | |||
| 2023-03-31 | -$0.10 10-Q · filed 2024-05-14 | ||||
| 2022-12-31 | $0.14 10-K · filed 2025-03-19 | ||||
| 2022-09-30 | $0.44 10-Q · filed 2023-11-09 | $0.25 10-Q · filed 2023-11-09 | |||
| 2022-06-30 | -$0.09 10-Q · filed 2023-08-09 | -$0.18 10-Q · filed 2023-08-09 | |||
| 2022-03-31 | -$0.10 10-Q · filed 2023-05-10 | ||||
| 2021-12-31 | -$0.47 10-K · filed 2024-03-19 | ||||
| 2021-09-30 | -$0.15 10-Q · filed 2022-11-09 | -$0.34 10-Q · filed 2022-11-09 | |||
| 2021-06-30 | -$0.10 10-Q · filed 2022-08-08 | -$0.19 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | -$0.09 10-Q · filed 2022-05-09 | ||||
| 2020-12-31 | -$1.02 10-K · filed 2023-03-06 | ||||
| 2020-09-30 | -$0.18 10-Q · filed 2021-11-08 | -$0.79 10-Q · filed 2021-11-08 | |||
| 2020-06-30 | -$0.26 10-Q · filed 2021-08-09 | -$0.61 10-Q · filed 2021-08-09 | |||
| 2020-03-31 | -$0.35 10-Q · filed 2021-05-10 | ||||
| 2019-12-31 | -$2.09 10-K · filed 2022-03-01 | ||||
| 2016-03-31 | -$0.55 10-Q · filed 2016-05-10 | ||||
| 2015-12-31 | -$0.28 10-K · filed 2017-03-01 | ||||
| 2015-09-30 | -$0.34 10-K · filed 2017-03-01 | ||||
| 2015-06-30 | -$0.37 10-K · filed 2017-03-01 | ||||
| 2015-03-31 | $0.26 10-K · filed 2017-03-01 | ||||
| 2014-12-31 | $0.19 10-K · filed 2016-02-29 | ||||
| 2014-09-30 | -$0.53 10-K · filed 2016-02-29 | -$1.02 10-Q · filed 2014-11-13 | |||
| 2014-06-30 | -$0.53 10-K · filed 2016-02-29 | ||||
| 2014-03-31 | $0.04 10-K · filed 2016-02-29 | ||||
| 2013-12-31 | -$0.13 10-K · filed 2015-03-02 | ||||
| 2013-09-30 | $0.15 10-K · filed 2015-03-02 | -$2.05 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | -$2.45 10-K · filed 2015-03-02 | -$2.44 10-K · filed 2014-03-31 | |||
| 2013-03-31 | -$7.54 10-K · filed 2015-03-02 | ||||
| 2012-09-30 | -$4.66 10-Q · filed 2013-11-07 | -$12.21 10-Q · filed 2013-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |